Your browser doesn't support javascript.
loading
A case of Mycobacterium tuberculosis laboratory cross-contamination.
Takeda, Keita; Murase, Yoshiro; Kawashima, Masahiro; Suzukawa, Maho; Suzuki, Junko; Yamane, Akira; Igarashi, Yuriko; Chikamatsu, Kinuyo; Morishige, Yuta; Aono, Akio; Yamada, Hiroyuki; Takaki, Akiko; Tamura, Atsuhisa; Nagai, Hideaki; Matsui, Hirotoshi; Tohma, Shigeto; Mitarai, Satoshi.
Afiliação
  • Takeda K; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan; Department of Basic Mycobacteriology, Graduate School of Biomedical Science, Nagasaki University, Japan. El
  • Murase Y; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: ymurase@jata.or.jp.
  • Kawashima M; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: mkawashima-in@tokyo-hosp.jp.
  • Suzukawa M; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: suzukawam@tokyo-hosp.jp.
  • Suzuki J; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: junkosz-in@tokyo-hosp.jp.
  • Yamane A; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: yamanea@tokyo-hosp.jp.
  • Igarashi Y; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: igarashi@jata.or.jp.
  • Chikamatsu K; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: chikamatsu@jata.or.jp.
  • Morishige Y; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: ymorishige@jata.or.jp.
  • Aono A; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: a.aono1967@gmail.com.
  • Yamada H; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: hyamada@jata.or.jp.
  • Takaki A; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan. Electronic address: takaki@jata.or.jp.
  • Tamura A; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: tamura-in@tokyo-hosp.jp.
  • Nagai H; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: hnagai-tokyohosp@umin.ac.jp.
  • Matsui H; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: matsui.hirotoshi.sa@mail.hosp.go.jp.
  • Tohma S; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan. Electronic address: touma-shigeto@tokyo-hosp.jp.
  • Mitarai S; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan; Department of Basic Mycobacteriology, Graduate School of Biomedical Science, Nagasaki University, Japan. Electronic address: mitarai@jata.or.jp.
J Infect Chemother ; 25(8): 610-614, 2019 Aug.
Article em En | MEDLINE | ID: mdl-30982725
SETTING: A laboratory cross-contamination event was suspected because Mycobacterium tuberculosis was unexpectedly detected at a high incidence in the cultures of several clinical specimens at the National Hospital Organization, Tokyo National Hospital, Japan. OBJECTIVE: To describe a case of Mycobacterium tuberculosis laboratory cross-contamination. DESIGN: We reviewed the medical records of 20 patients whose clinical specimens were suspected to have been contaminated by Mycobacterium tuberculosis. Variable number of tandem repeat analysis with 15 loci, the Japan Anti-Tuberculosis Association-12, and three additional hyper-variable loci, was performed to identify the cross-contamination event. RESULTS: The clinical, laboratory, and variable number of tandem repeat data revealed that the cross-contamination had possibly originated from one strongly positive specimen, resulting in false-positive results in 11 other specimens, including a case treated with anti-tuberculosis drugs. CONCLUSION: Clinical and laboratory data must be re-evaluated when cross-contamination is suspected and variable number of tandem repeat analysis should be used to confirm cross-contamination. Furthermore, original isolates should be stored appropriately, without sub-culturing and genotyping should be performed at the earliest possible for better utilization of variable number of tandem repeat for the identification of cross-contamination.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article